Home Page/Money
Local Headlines


Features
Stocks Unmoved By Cheaper Oil
The market held token gains as crude prices fell below $48 a barrel. Merck faced new investigations into the marketing of Vioxx despite the drug's heightened heart risks. Marsh & McLennan's effort to mollify insurance regulators hurt earnings.

Obese Executives Spend More On Prescription Drugs

More From SmartMoney
More Stories

Oil Stocks Look Like A Dry Hole
Despite lofty prices at the gas pump, analysts don't see 2004 shaping up as a gusher for energy stocks -- at least for most of them

A Made-to-Order Megamerger
Jamie Dimon's Bank One will supply William Harrison's J.P. Morgan Chase with the top talent it needed to take on Citibank

Yahoo: Still An Online Ad Play
Though Terry Semel may try to spin it as a more diversified company, the portal's robust earnings are the result of a robust ad market

Who Will Fastow Implicate?
Enron's ex-CFO is a loose cannon who could shoot in several directions, at a string of Enron execs, bankers, and lawyers

More From BusinessWeek Online
Updated 1:49 EDT
 Dow 10108.15 
43.40 
 Nasdaq 1912.55 
2.65 
 NYSE 6430.34 
26.07 
Quick Quotes
 
enter name or symbol